Caruso I, Di Gioia L, Di Molfetta S et al (2023) Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis
Refined Carbohydrates and Sugary Foods to Limit Tirzepatide is a dual GLP-1 and GIP receptor agonist designed to improve blood sugar control and reduce cravings
Evaluate and Replete Key Nutrient Deficiencies GLP-1 medications can lower intake and absorption of nutrients that regulate gut function: Mag Citrate : critical for smooth muscle relaxation Potassium : supports peristalsis Vitamin B6 and B12 : help produce neurotransmitters that regulate gut tone Use our Micronutrient Lab to test levels and guide targeted supplementation
Tirzepatide is a dual GLP-1 and GIP receptor agonist administered once weekly, and the timing of your injection significantly influences appetite suppression, blood sugar stability, and weight loss outcomes
107 TMAO is a potential risk factor for cardiovascular complications in patients with CKD
Clinical trials show that consistent injection technique improves medication stability and reduces side effect variability
